CR Shuanghe: No.0 of main product decompression is expected to increase by 10% year on year
-
Last Update: 2013-09-11
-
Source: Internet
-
Author: User
Search more information of high quality chemicals, good prices and reliable suppliers, visit
www.echemi.com
Wang Jian, head of investor relations at China Resources Shuanghe (600062 SH), said at a strategic meeting organized by a securities firm today that the company's main product No Jiangya 0 is the core product of Cr Shuanghe's cardio cerebrovascular product line In 2012, it sold 1.05 billion tablets, accounting for about 70% - 80% of the cardio cerebrovascular products In the first quarter of this year, under the influence of channel reform and higher base in the same period last year, product sales fell 27% year on year Wang Jian pointed out that Jiangya No 0 is a mature product of the company with a large base The company's future marketing focus is on the county and township communities to maintain the annual growth of the product by 10%.
This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only.
This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of
the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed
description of the concern or complaint, to
service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content
will be removed immediately.
